Carob pod aqueous extract potentiates cisplatin efficacy and reduces toxicity in experimental hepatocellular carcinoma via mitochondrial and inflammatory pathway modulation

Abstract

Background

Hepatocellular carcinoma (HCC) is a global health challenge with limited therapeutic options. The effectiveness of conventional medication like cisplatin is often compromised by their severe toxicity. This study investigated carob pod aqueous extract (CPAE), a polyphenol-rich natural product, as a potential adjunct therapy to enhance efficacy and mitigate cisplatin toxicity in a preclinical HCC animal model.

Methods

A rat model of HCC was established using diethylnitrosamine (DEN) and carbon tetrachloride (CCl₄). Forty-two Wistar rats were divided into seven groups, receiving various treatments: control, CPAE, vehicle, HCC only, HCC+CPAE, HCC+cisplatin, and HCC+CPAE+cisplatin. Liver and kidney function, metabolic profiles, oxidative stress/antioxidant parameters, gene and protein expression (AMPK, PGC-1α, TFAM, SIRT1, iNOS, NF-κB, IκK, p53, SREBP-2), histopathology, and statistical analyses were performed.

Results

HCC induction caused significant liver dysfunction, metabolic disturbances, oxidative stress, alongside dysregulation of AMPK/PGC-1α/TFAM and NF-κB/iNOS pathways. CPAE, alone or with cisplatin, markedly ameliorated these changes, improving liver and kidney function, restoring antioxidant status, reducing the tumor marker AFP, suppressing pro-inflammatory and oncogenic signaling, and enhancing histological architecture. Furthermore, Combination therapy demonstrated synergistic benefits, with CPAE reducing cisplatin-induced nephrotoxicity and enhancing its antitumor efficacy, primarily via modulation of mitochondrial biogenesis, redox balance, and inflammatory signaling.

Conclusions

CPAE exhibits potent hepatoprotective and anti-HCC activity, especially when combined with cisplatin. This combination modulates mitochondrial and inflammatory pathways while mitigating cisplatin-induced toxicity. These finding position CPAE as a promising natural adjuvant for integrative HCC management. Further translational studies are warranted to validate these findings and explore clinical applicability.

Graphical abstract

Keywords

Hepatocellular carcinoma / Carob pod aqueous extract / Mitochondrial biogenesis / Oxidative stress / Combination therapy

References

[1] Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. Cancer J Clin 74(1). https://doi.org/10.3322/caac.21820

[2] Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Therapy, 2025, 10(1): 35.

[3] Lee H-Y, Nga HT, Tian J, Yi H-S (2021) Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma. Cells, 10(8), 1901. https://doi.org/10.3390/cells10081901

[4] Bian J, Zhang D, Wang Y, Qin H, Yang W, Cui R, Sheng J. Mitochondrial Quality Control in Hepatocellular Carcinoma. Front Oncol, 2021, 11(September): 1-14.

[5] Hinchy EC, Gruszczyk AV, Willows R, Navaratnam N, Hall AR, Bates G, Bright TP, Krieg T, Carling D, Murphy MP. Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly. J Biol Chem, 2018, 293(44): 17208-17217.

[6] Rabinovitch RC, Samborska B, Faubert B, Ma EH, Gravel S-P, Andrzejewski S, Raissi TC, Pause A, Pierre JS, Jones RG. AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Rep, 2017, 21(1): 1-9.

[7] Sun Z, Linares B, Urdiales C, Al-Sarmi F, Putluri N, Van Nostrand JL (2025) AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity. BioRxiv: The Preprint Server for Biology. https://doi.org/10.1101/2025.05.16.652569

[8] Jiang X, Tan HY, Teng S, Chan YT, Wang D, Wang N (2019) The role of AMP-activated protein kinase as a potential target of treatment of hepatocellular carcinoma. Cancers 11(5). https://doi.org/10.3390/cancers11050647

[9] Krupa K, Fudalej M, Cencelewicz-Lesikow A, Badowska-Kozakiewicz A, Czerw A, Deptała A. Current Treatment Methods in Hepatocellular Carcinoma. Cancers, 2024, 16(23): 1-22.

[10] Chen C, Ai Qdi, Wei Yhui (2021) Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux. Journal of Ethnopharmacology, 264(September 2020). https://doi.org/10.1016/j.jep.2020.113388

[11] Dong H, Huang J, Zheng K, Tan D, Chang Q, Gong G, Zhang Q, Tang H, Sun J, Zhang S. Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway. Oncol Lett, 2017, 14(6): 7807-7812.

[12] Elmorsy EA, Saber S, Hamad RS, Abdel-Reheim MA, El-Kott AF, AlShehri MA, Morsy K, Salama SA, Youssef ME. Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies. Eur J Pharm Sci, 2024, 203: 106939.

[13] Pan X, Zhou J, Chen Y, Xie X, Rao C, Liang J, Zhang Y, Peng C. Classification, hepatotoxic mechanisms, and targets of the risk ingredients in traditional Chinese medicine-induced liver injury. Toxicol Lett, 2020, 323: 48-56.

[14] Rtibi K, Selmi S, Grami D, Amri M, Eto B, El-Benna J, Sebai H, Marzouki L. Chemical constituents and pharmacological actions of carob pods and leaves (Ceratonia siliqua L.) on the gastrointestinal tract: A review. Biomed Pharmacotherapy, 2017, 93(September): 522-528.

[15] Rasheed DM, El-Kersh DM, Farag MA (2019) Ceratonia siliqua (carob-locust bean) outgoing and potential trends of phytochemical, economic and medicinal merits. Wild Fruits: Composition, Nutritional Value and Products. Springer, pp 481–498

[16] Darwish WS, Khadr AES, Kamel MAEN, Eldaim A, Sayed MAE, Abdel-Bary IET, Ullah HM, Ghareeb DA. Phytochemical Characterization and Evaluation of Biological Activities of Egyptian Carob Pods (Ceratonia siliqua L.) Aqueous Extract: In Vitro Study. Plants, 2021, 10(12): 2626.

[17] Uehara T, Pogribny IP, Rusyn I (2014) The DEN and CCl4-induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma. Current Protocols Pharmacology 2014(September) 14(301–). https://doi.org/10.1002/0471141755.ph1430s66

[18] Elhalim SAA, Sharada HM, Abulyazid I, Aboulthana WM, Elhalim STA. Ameliorative effect of carob pods extract (Ceratonia siliqua L.) against cyclophosphamide induced alterations in bone marrow and spleen of rats. J Appl Pharm Sci, 2017, 7(10): 168-181.

[19] Tappel AL, Zalkin H. Inhibition of lipide peroxidation in mitochondria by vitamin E. Arch Biochem Biophys, 1959, 80(2): 333-336.

[20] Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med, 2007, 43(5): 645-657.

[21] Litwack G, Bothwell JW, Williams JN, Elvehjem CA. A colorimetric assay for xanthine oxidase in rat liver homogenates. J Biol Chem, 1953, 200(1): 303-310.

[22] Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology, 1974, 11(3): 151-169.

[23] Pierce S, Tappel AL. Glutathione peroxidase activities from rat liver. Biochim et Biophys Acta (BBA) - Enzymol, 1978, 523(1): 27-36.

[24] Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem, 1974, 249(22): 7130-7139.

[25] Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem, 1974, 47(3): 469-474.

[26] Candeias MF, Abreu P, Pereira A, Cruz-Morais J. Effects of strictosamide on mouse brain and kidney Na+, K+-ATPase and Mg2+-ATPase activities. J Ethnopharmacol, 2009, 121(1): 117-122.

[27] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 – ∆∆CT method. Methods, 2001, 25(4): 402-408.

[28] Burnette WN. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem, 1981, 112(2): 195-203.

[29] You Y, Zhu F, Li Z, Zhang LF, Xie Y, Chinnathambi A, Alahmadi TA, Lu B. Phyllanthin prevents diethylnitrosamine (DEN) induced liver carcinogenesis in rats and induces apoptotic cell death in HepG2 cells. Biomed Pharmacotherapy, 2021, 137(February): 111335.

[30] Santos NP, Colaço AA, Oliveira PA (2017) Animal models as a tool in hepatocellular carcinoma research: A Review. Tumor Biology 39(3). https://doi.org/10.1177/1010428317695923

[31] Abdel-Hamid NM, Allah A, Hassan SG, Ahmed MK, Anber AAM, Faried A. Possible Protective Potency of Argun Nut (Medemia argun–An Ancient Egyptian Palm) against Hepatocellular Carcinoma in Rats. Nutr Cancer, 2021, 0(0): 1-12.

[32] Hamza AA, Heeba GH, Hamza S, Abdalla A, Amin A (2021) Standardized extract of ginger ameliorates liver cancer by reducing proliferation and inducing apoptosis through inhibition oxidative stress/ inflammation pathway. Biomedicine and Pharmacotherapy, 134(December 2020), 111102. https://doi.org/10.1016/j.biopha.2020.111102

[33] Abass SA, El-Hamid NMA, Abouzed TK, El-Shishtawy MM. Chemosensitizing effect of Alpinia officinarum rhizome extract in cisplatin-treated rats with hepatocellular carcinoma. Biomed Pharmacotherapy, 2018, 101(October 2017): 710-718.

[34] Jain D (2014) Tissue diagnosis of hepatocellular carcinoma. J Clin Experimental Hepatol 4(Suppl 3). https://doi.org/10.1016/j.jceh.2014.03.047. S67-73

[35] Bashandy SAE, Ebaid H, Al-Tamimi J, Hassan I, Omara EA, Elbaset MA, Alhazza IM, Siddique JA. Protective effect of daidzein against diethylnitrosamine/carbon tetrachloride-induced hepatocellular carcinoma in male rats. Biology, 2023, 12(9): 1184.

[36] Arboatti AS, Lambertucci F, Sedlmeier MG, Pisani G, Monti J, Álvarez MDL, Francés DEA, Ronco MT, Carnovale CE (2018) Diethylnitrosamine increases proliferation in early stages of hepatic carcinogenesis in insulin-treated type 1 diabetic mice. Biomed Res Int 20182009. https://doi.org/10.1155/2018/9472939

[37] Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS (2021) Hepatocellular carcinoma. Nat Reviews Disease Primers 7(1). https://doi.org/10.1038/s41572-020-00240-3

[38] Wu H, Qu L, Bai X, Zhu C, Liu Y, Duan Z, Liu H, Fu R, Fan D. Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway. Food Chem Toxicol, 2024, 186: 114587.

[39] Mo’men YS, Hussein RM, Kandeil MA. A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade. Clin Exp Pharmacol Physiol, 2020, 47(2): 322-332.

[40] Assar DH, Mokhbatly AAA, Ghazy EW, Ragab AE, Asa SA, Abdo W, Elbialy ZI, Mohamed NE, El-Far AH (2021) Ameliorative effects of aspergillus awamori against the initiation of hepatocarcinogenesis induced by diethylnitrosamine in a rat model: Regulation of cyp19 and p53 gene expression. Antioxidants 10(6). https://doi.org/10.3390/antiox10060922

[41] Mastropasqua F, Girolimetti G, Shoshan M. PGC1α: Friend or Foe in Cancer?. Genes, 2018, 9(1): 48.

[42] Elazab ST, Safhi FA, Al-Akeel RK, Deraz RH, Sarkar S, Gamal Eldin REA. Gallic Acid and Taurine Attenuate Thiamethoxam-Induced Hepatotoxicity in Rats by Modulating SIRT-1/PGC-1α, NF-κB/iNOS, and p53/Bax/Caspase-3 Pathways. Pharmaceuticals, 2025, 18(8): 1112.

[43] Zhao M, Wang Y, Li L, Liu S, Wang C, Yuan Y, Yang G, Chen Y, Cheng J, Lu Y. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics, 2021, 11(4): 1845.

[44] Kang I, Chu CT, Kaufman BA, Protein C. neurodegeneration: Emerging evidence and mechanisms. FEBS Lett, 2018, 592(5): 793-811.

[45] Silva Ramos E, Motori E, Brüser C, Kühl I, Yeroslaviz A, Ruzzenente B, Kauppila JHK, Busch JD, Hultenby K, Habermann BH. Mitochondrial fusion is required for regulation of mitochondrial DNA replication. PLoS Genet, 2019, 15(6): e1008085.

[46] Hsiao Y-F, Huang S-C, Cheng S-B, Hsu C-C, Huang Y-C. Glutathione and selenium supplementation attenuates liver injury in diethylnitrosamine-induced hepatocarcinogenic mice by enhancing glutathione-related antioxidant capacities. Int J Mol Sci, 2024, 25(21): 11339.

[47] Ahmad Z, Ishfaq PM, Jain SK, Mishra SK. Mitigation of experimental hepatocellular Carcinoma by Inonotus obliquus Mushroom extract in association with oxidative stress and inflammation signaling. Environ Toxicol Pharmacol, 2025, 114: 104648.

[48] Gani SA, Muhammad SA, Kura AU, Barahuie F, Hussein MZ, Fakurazi S. Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice. PLoS ONE, 2019, 14(5): 1-24.

[49] El-Magd MA, Mohamed Y, El-Shetry ES, Elsayed SA, Abo Gazia M, Abdel-Aleem GA, Shafik NM, Abdo WS, El-Desouki NI, Basyony MA. Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCC. Biomed Pharmacotherapy, 2019, 114(February): 108732.

[50] Xiang H, Lan Y, Hu L, Qin R, Li H, Weng T, Zou Y, Liu Y, Hu X, Ge W. AMPK activation mitigates inflammatory pain by modulating STAT3 phosphorylation in inflamed tissue macrophages of adult male mice. Mol Pain, 2025, 21: 17448069251321340.

[51] Fu X, Qie J, Chen J, Gao Z, Li X, Feng S, Dong E, Shi Y, Tang Z, Liu W. Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation. Int J Biol Macromol, 2024, 278: 134120.

[52] Zheng Z, Bian Y, Zhang Y, Ren G, Li G. Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis. Cell Cycle, 2020, 19(10): 1089-1104.

[53] Li Y, Xu S, Li J, Zheng L, Feng M, Wang X, Han K, Pi H, Li M, Huang X, You N, Tian Y, Zuo G, Li H, Zhao H, Deng P, Yu Z, Zhou Z, Liang P. SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis. Oncotarget, 2016, 7(20): 29255-29274.

[54] Zeng R, Shen L, Ye T, Xu W, Huang K, Qiu F, Liu C, Hu X (2025) Levistilide A Attenuates Carbon Tetrachloride (CCl4)-Induced Liver Fibrosis by Inhibiting the NF-κB/iNOS/NO Signalling Pathway in M1 Macrophages. J Ethnopharmacol 120074. https://doi.org/10.1016/j.jep.2024.120074

[55] Tanaka M, Sato A, Kishimoto Y, Mabashi-Asazuma H, Kondo K, Iida K (2020) Gallic acid inhibits lipid accumulation via ampk pathway and suppresses apoptosis and macrophage-mediated inflammation in hepatocytes. Nutrients 12(5). https://doi.org/10.3390/nu12051479

[56] Atya ME, El-Hawiet A, Alyeldeen MA, Ghareeb DA, Abdel-Daim MM, El-Sadek MM. In vitro biological activities and in vivo hepatoprotective role of brown algae-isolated fucoidans. Environ Sci Pollut Res, 2021, 28(16): 19664-19676.

[57] Martić N, Zahorec J, Stilinović N, Andrejić-Višnjić B, Pavlić B, Kladar N, Šoronja-Simović D, Šereš Z, Vujčić M, Horvat O. Hepatoprotective effect of carob pulp flour (Ceratonia siliqua L.) extract obtained by optimized microwave-assisted extraction. Pharmaceutics, 2022, 14(3): 657.

[58] El-haskoury R, Al-Waili N, Kamoun Z, Makni M, Al-Waili H, Lyoussi B. Antioxidant Activity and Protective Effect of Carob Honey in CCl4-induced Kidney and Liver Injury. Arch Med Res, 2018, 49(5): 306-313.

[59] Al-Olayan EM, El-Khadragy MF, Alajmi RA, Othman MS, Bauomy AA, Ibrahim SR, Abdel Moneim AE. Ceratonia siliqua pod extract ameliorates Schistosoma mansoni-induced liver fibrosis and oxidative stress. BMC Complement Altern Med, 2016, 16(1): 1-11.

[60] Aly SM, Fetaih HA, Hassanin AAI, Abomughaid MM, Ismail AA (2019) Protective effects of garlic and cinnamon oils on hepatocellular carcinoma in albino rats. Anal Cell Pathol 2019(17). https://doi.org/10.1155/2019/9895485

[61] Aglan HA, Ahmed HH, El-Toumy SA, Mahmoud NS (2017) Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study. Tumor Biology 39(6). https://doi.org/10.1177/1010428317699127

[62] Shi C, Zheng Y, Pan F, Zhang F, Zhuang P, Fu W (2021) Gallic acid suppressed tumorigenesis by an LncRNA MALAT1-Wnt/β-catenin axis in hepatocellular carcinoma. In Frontiers in Pharmacology (Vol. 12, p. 2517). https://www.frontiersin.org/article/https://doi.org/10.3389/fphar.2021.708967

[63] Lin H, Chen J, Chou F, Wang C. Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF‐κB pathway and MMP‐2 production by targeting RhoB activation. Br J Pharmacol, 2011, 162(1): 237-254.

[64] Shimizu M, Shirakami Y, Sakai H, Kubota M, Kochi T, Ideta T, Miyazaki T, Moriwaki H. Chemopreventive potential of green tea catechins in hepatocellular carcinoma. Int J Mol Sci, 2015, 16(3): 6124-6139.

[65] Hong R, Min S, Huang J, Zou M, Zhou D, Liang Y. High-dose vitamin C promotes mitochondrial biogenesis in HCT116 colorectal cancer cells by regulating the AMPK/PGC-1α signaling pathway. J Cancer Res Clin Oncol, 2025, 151(5): 167.

[66] Liu J, Wang Y, Qiao P, Ying Y, Lin S, Lu F, Zhou H. Mechanisms of Cisplatin-Induced Acute Kidney Injury: The Role of NRF2 in Mitochondrial Dysfunction and Metabolic Reprogramming. Antioxidants, 2025, 14(7): 775.

[67] Gao ZX, Zhang ZS, Qin J, Zhang MZ, Cao JL, Li YY, Xie SQ. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma. Phytomedicine, 2023, 112: 154715.

[68] Wu PY, Hasanah U, Yang SH, Chen SY, Luo YH, Chen CC, Chen SC. Enhancing cisplatin efficacy in hepatocellular carcinoma with selenocystine: The suppression of DNA repair and inhibition of proliferation in hepatoma cells. Chemico-Biol Interact, 2025, 405: 111291.

[69] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J biol Chem, 1951, 193(1): 265-275.

[70] Shaban NZ, Abdelrahman SA, El-Kersh MA, Mogahed FA, Talaat IM, Habashy NH. The synergistic hepatoprotective potential of Beta vulgaris juice and 2, 3-dimercaptosuccinic acid in lead-intoxicated rats via improving the hepatic oxidative and inflammatory stress. BMC Complement Med Ther, 2020, 20(1): 268.

[71] Li L, Li SM, Sun JH, Zhou LL, Bao XG, Zhang HG, Zhang FS. Diversity enhances agricultural productivity via rhizosphere phosphorus facilitation on phosphorus-deficient soils. Proc Natl Acad Sci, 2007, 104(27): 11192-11196.

[72] Ishteyaque, S., Singh, G., Yadav, K. S., Verma, S., Sharma, R. K., Sen, S., … Mugale,M. N. (2024). Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma. Metabolism, 152, 155771

[73] Atta AH, Atta SA, Khattab MS, El-Aziz THA, Mouneir SM, Ibrahim MA, Emam SR. C eratonia siliqua pods (Carob) methanol extract alleviates doxorubicin-induced nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic pathways in rats. Environ Sci Pollut Res, 2023, 30(35): 83421-83438.

[74] Huang S, You J, Wang K, Li Y, Zhang Y, Wei H, Liu Y. N-Acetylcysteine Attenuates Cisplatin‐Induced Acute Kidney Injury by Inhibiting the C5a Receptor. Biomed Res Int, 2019, 20191: 4805853

[75] Zavala-Valencia AC, Velasco-Hidalgo L, Martínez-Avalos A, Castillejos-López M, Torres-Espíndola LM (2024) Effect of N-acetylcysteine on cisplatin toxicity: A review of the literature. Biol Targets Ther, 7–19

[76] Fang, C. Y., Lou, D. Y., Zhou, L. Q., Wang, J. C., Yang, B., He, Q. J., … Weng, Q.J. (2021). Natural products: potential treatments for cisplatin-induced nephrotoxicity.Acta Pharmacologica Sinica, 42(12), 1951–1969.

RIGHTS & PERMISSIONS

The Author(s)